Vaglini M - Search Results

1

Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.

Koops HS, Vaglini M, Suciu S, Kroon BB, Thompson JF, Göhl J, Eggermont AM, Di Filippo F, Krementz ET, Ruiter D, Lejeune FJ. Koops HS, et al. Among authors: vaglini m. J Clin Oncol. 1998 Sep;16(9):2906-12. doi: 10.1200/JCO.1998.16.9.2906. J Clin Oncol. 1998. PMID: 9738557 Clinical Trial.

2

Hyperthermic antiblastic perfusion in the treatment of stage IIIA-IIIAB melanoma patients. Comparison of two experiences.

Cavaliere R, Cavaliere F, Deraco M, Di Filippo F, Santinami M, Schiratti M, Anzà M, Vaglini M. Cavaliere R, et al. Among authors: vaglini m. Melanoma Res. 1994 Mar;4 Suppl 1:5-11. Melanoma Res. 1994. PMID: 8038597 Clinical Trial.

3

Soft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusion.

Rossi CR, Foletto M, Di Filippo F, Vaglini M, Anza' M, Azzarelli A, Pilati P, Mocellin S, Lise M. Rossi CR, et al. Among authors: vaglini m. Cancer. 1999 Nov 1;86(9):1742-9. doi: 10.1002/(sici)1097-0142(19991101)86:9<1742::aid-cncr16>3.0.co;2-g. Cancer. 1999. PMID: 10547547 Clinical Trial.

4

Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I study.

Di Filippo F, Rossi CR, Vaglini M, Azzarelli A, Anzà M, Santinami M, Lise M, Cavaliere F, Giannarelli D, Quagliuolo V, Vecchiato A, Deraco M, Garinei R, Foletto M, Botti C, Cavaliere R. Di Filippo F, et al. Among authors: vaglini m. J Immunother. 1999 Sep;22(5):407-14. doi: 10.1097/00002371-199909000-00004. J Immunother. 1999. PMID: 10546156 Clinical Trial.

5

Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan.

Vaglini M, Belli F, Ammatuna M, Inglese MG, Manzi R, Prada A, Persiani L, Santinami M, Santoro N, Cascinelli N. Vaglini M, et al. Cancer. 1994 Jan 15;73(2):483-92. doi: 10.1002/1097-0142(19940115)73:2<483::aid-cncr2820730238>3.0.co;2-s. Cancer. 1994. PMID: 8293417 Clinical Trial.

6

Treatment of recurrent sarcoma of the extremities by isolated limb perfusion using tumor necrosis factor alpha and melphalan.

Santinami M, Deraco M, Azzarelli A, Cascinelli F, Chiti A, Costagli V, Inglese MG, Manzi R, Quagliolo V, Rebuffoni G, Santoro N, Vaglini M. Santinami M, et al. Among authors: vaglini m. Tumori. 1996 Nov-Dec;82(6):579-84. doi: 10.1177/030089169608200613. Tumori. 1996. PMID: 9061068

7

Treatment of in-transit metastases from cutaneous melanoma by isolation perfusion with tumour necrosis factor-alpha (TNF-alpha), melphalan and interferon-gamma (IFN-gamma). Dose-finding experience at the National Cancer Institute of Milan.

Vaglini M, Santinami M, Manzi R, Inglese MG, Santoro N, Persiani L, Belli F. Vaglini M, et al. Melanoma Res. 1994 Mar;4 Suppl 1:35-8. Melanoma Res. 1994. PMID: 8038594 Clinical Trial.

8

Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities.

Santinami M, Belli F, Cascinelli N, Rovini D, Vaglini M. Santinami M, et al. Among authors: vaglini m. J Surg Oncol. 1989 Nov;42(3):201-8. doi: 10.1002/jso.2930420315. J Surg Oncol. 1989. PMID: 2811386

9

TNF-alpha and doxorubicin in hyperthermic perfusion for limb sarcomas.

Rossi C, Foletto M, Vecchiato A, Menin N, Pizzirani E, Difilippo F, Vaglini M, Santinami M, Azzarelli A, Cavaliere R, Lise M. Rossi C, et al. Among authors: vaglini m. Oncol Rep. 1996 Nov;3(6):1059-61. doi: 10.3892/or.3.6.1059. Oncol Rep. 1996. PMID: 21594507

10

The role of parotidectomy in the treatment of nodal metastases from cutaneous melanoma of the head and neck.

Vaglini M, Belli F, Santinami M, Cascinelli N. Vaglini M, et al. Eur J Surg Oncol. 1990 Feb;16(1):28-32. Eur J Surg Oncol. 1990. PMID: 2307240

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page